PharmiWeb
Polish Ministry of Health approves reimbursement of POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome
Galashiels and Marlow, United Kingdom, and Baar, Switzerland, 31 July 2024—Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co. Ltd., and Swixx BioPharma AG today announced ...
1 day ago